Lumito
1.238 SEK -0.8%Be the first to follow this company
Lumito specializes in medical technology for digital pathology. The company strives to improve tissue diagnostics with its patented technology based on upconverted nanoparticles. The company plans to initially launch its first product for research laboratories. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito has its headquarters in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
LUMITO
Daily low / high price
1.21 / 1.248
SEK
Market cap
255.57M SEK
Turnover
193.54K SEK
Volume
157K
Financial calendar
General meeting
2024-05-07
Interim report
2024-05-07
Interim report
2024-08-23
Interim report
2024-10-31
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.3 % | 7.3 % |
Nordnet Pensionsförsäkring AB | 2.4 % | 2.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Årsredovisning för 2023
KALLELSE TILL ÅRSSTÄMMA I LUMITO AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools